# Chapter 96. RNA-Chromatin Mechanisms, Regulatory Consequences, and Causality

## Scope Note

RNA-chromatin interactions describe cases in which RNA molecules remain physically or functionally connected to chromosomal DNA, nucleosomes, histone-modifying enzymes, chromatin-remodeling complexes, architectural proteins, or transcriptional condensates. This chapter owns mechanistic recruitment models, PRC2-RNA specificity and consequences, enhancer and promoter RNA functions, RNA tethering, chromatin remodeling, histone modification, and causal inference. Named-assay workflows and bias tutorials belong to [Chapter 134](chapter1122.md); methods appear here only as evidence bridges. The scope is eukaryotic nuclear biology, with emphasis on mammalian systems.

## Executive Summary

Chromatin is not a DNA-protein material that happens to be transcribed; many nuclear RNAs remain near their sites of synthesis or associate with chromatin regulators, thereby creating opportunities for RNA to influence local chromatin state. Some RNA-chromatin relationships are direct and causal, such as a cis-acting lncRNA that helps concentrate regulatory factors at a neighboring genomic domain. Others are indirect consequences of transcription, chromatin accessibility, enhancer activity, or nuclear compartmentalization. A central problem in this field is that RNA occupancy, regulator binding, histone marks, chromatin contacts, and gene expression often change together, but these measurements do not by themselves establish the order of causality.

Several recruitment models are used to explain RNA-chromatin regulation. In a guide model, an RNA contains sequence or structural information that directs a protein complex to a genomic region. In a scaffold model, an RNA organizes multiple proteins into a regulatory complex. In a tether model, nascent transcription or RNA retention keeps an RNA near the chromosomal region that produced it. In an allosteric or decoy model, RNA binding changes the activity, substrate choice, or availability of a chromatin regulator. These models are useful, but they overlap. A single RNA can tether locally through transcription, bind a protein through a repeated sequence element, and modulate enzymatic activity without acting as a precise address label.

Polycomb repressive complex 2 (PRC2) illustrates both the promise and the hazards of the field. PRC2 deposits H3K27me3, a histone mark associated with facultative repression. Many RNAs bind PRC2 subunits in vitro or in cells, and some lncRNAs have been proposed to recruit PRC2 to specific loci. However, PRC2 can bind RNA broadly, and RNA binding can inhibit or modulate PRC2 catalytic activity under some conditions. The specificity debate is therefore not whether PRC2 can bind RNA, but whether a particular RNA interaction is selective enough, localized enough, and functionally necessary enough to explain Polycomb targeting at a genomic site. Current consensus is cautious: PRC2-RNA contacts are biologically real in many contexts, but evidence for simple RNA-guided recruitment must be evaluated case by case.

Enhancer and promoter RNAs add another layer. Active enhancers are frequently transcribed by RNA polymerase II, often producing short, unstable, bidirectional enhancer RNAs. These transcripts can be markers of enhancer activity, but in some settings the RNA molecule, the act of transcription, or nascent RNA-associated proteins contribute to enhancer-promoter communication, chromatin accessibility, mediator or cohesin behavior, or local histone modification. Recent studies linking enhancer RNA m6A, chromatin accessibility, and oncogene expression, and studies of RNA polymerase II dynamics at enhancer-promoter contacts, show that enhancer transcription cannot be reduced to a passive readout. Still, enhancer RNA function requires strong perturbation evidence because deleting an enhancer DNA element, blocking transcription, degrading the RNA, and disrupting a chromatin loop can produce overlapping phenotypes through different mechanisms.

Methodologically, RNA-chromatin biology requires triangulation. RNA-centric mapping methods such as ChIRP, CHART, and RAP identify genomic regions associated with a chosen RNA, whereas global proximity ligation methods such as GRID-seq map many RNA-DNA contacts in parallel. Imaging methods test whether RNA and genomic loci co-localize in single cells and whether contacts are stable, transient, or cell-cycle dependent. Perturbation standards include RNA depletion, transcriptional interference, locus deletion, protein-factor perturbation, rescue with tethered or mutant RNA, and measurement of chromatin marks, accessibility, contacts, and expression. The strongest claims combine molecular proximity, specificity controls, acute perturbation, and a mechanism that separates RNA sequence, RNA abundance, transcription, and DNA regulatory element effects.

## Concept Inventory

- **RNA-chromatin interaction:** a physical or functional association between an RNA molecule and a chromosomal region or chromatin-associated protein complex. The term should not be used as a synonym for gene regulation unless perturbation establishes functional consequence.
- **Chromatin-associated RNA:** RNA recovered with chromatin fractions or observed near chromosomal material. This category includes nascent transcripts, retained introns, lncRNAs, enhancer RNAs, repeat RNAs, and RNA fragments. Fractionation alone cannot prove direct binding to DNA or nucleosomes.
- **Cis-acting RNA:** an RNA whose main effect occurs near the genomic locus from which it is transcribed. Cis action can result from RNA sequence, RNA structure, transcription through the locus, splicing, RNA retention, or DNA element function.
- **Trans-acting RNA:** an RNA that influences loci away from its transcription site. Trans action requires evidence that the RNA molecule can leave its locus, reach targets, and act there at relevant concentration.
- **PRC2:** Polycomb repressive complex 2, a histone methyltransferase complex that includes EZH1 or EZH2, SUZ12, EED, and accessory subunits. PRC2 catalyzes H3K27 methylation, especially H3K27me3, and participates in facultative heterochromatin.
- **Enhancer RNA:** a transcript produced from an active enhancer. Most enhancer RNAs are short, unstable, and nonpolyadenylated, but enhancer transcripts vary widely in processing, stability, directionality, and function.
- **RNA tethering:** a mechanism in which an RNA is kept near a genomic locus by transcription, RNA-DNA hybrid formation, RNA-protein binding, RNA processing, or artificial recruitment. Tethering tests ask whether local RNA concentration is sufficient to alter chromatin state.
- **RNA-centric chromatin mapping:** experimental strategies that purify or tag a chosen RNA and identify associated DNA, proteins, or chromatin features. ChIRP, CHART, and RAP are major examples.
- **Global RNA-DNA proximity mapping:** strategies that ligate or otherwise capture many RNA-DNA contacts across the nucleus, including GRID-seq and related methods. These approaches provide broad maps but need careful interpretation of proximity, ligation efficiency, and abundance biases.

## What to Know Before Reading This Chapter

The reader should distinguish chromatin state from gene expression. Chromatin state refers to nucleosome positioning, histone modification, DNA methylation, accessibility, chromatin compaction, and three-dimensional contacts. Gene expression is the production and processing of RNA and, for coding genes, protein. These processes influence each other, but a change in RNA abundance is not automatically a chromatin mechanism.

The reader should also understand that RNA polymerase II transcription produces nascent RNA while the polymerase remains attached to DNA. A newly made RNA can therefore appear chromatin-associated simply because it has not yet been released, spliced, cleaved, degraded, or exported. This is especially important for enhancer RNAs and promoter-associated transcripts, which are often unstable and are detected most clearly by nascent RNA methods.

Finally, the reader should treat proximity methods as evidence of molecular neighborhood, not proof of regulatory function. ChIRP, CHART, RAP, GRID-seq, imaging, and proximity ligation can identify candidate contacts. Functional interpretation requires perturbation that separates the role of the RNA molecule from the role of the underlying DNA element, transcriptional activity, and associated proteins.

## 96.1. RNA-binding chromatin regulators and mechanistic recruitment models

### Chromatin-Associated RNA Is a Mechanistic Category, Not One Kind of Molecule

Chromatin-associated RNA includes several physically different entities. A nascent pre-mRNA can remain connected to chromatin through RNA polymerase II and spliceosome assembly. A lncRNA can accumulate near its transcription locus because transcription, processing, or nuclear retention constrains diffusion. An enhancer RNA can mark a regulatory element that is accessible, acetylated, and engaged with transcriptional coactivators. Repeat-derived RNAs can bind architectural proteins or contribute to heterochromatin organization. Small RNAs can guide chromatin regulation in organisms that use RNA interference pathways for transcriptional silencing. In mammalian cells, the most debated examples are lncRNAs, enhancer RNAs, promoter-associated RNAs, and repeat RNAs.

The mechanistic question is therefore not simply "does RNA bind chromatin?" The better question is which RNA species, in which cell state, through which molecular contact, changes which chromatin property, and with what evidence for causality. A chromatin fraction contains nascent transcripts and proteins that co-sediment with DNA. A formaldehyde-crosslinked RNA-centric pull-down can recover nearby DNA even when the RNA does not base-pair with that DNA. A microscopy image can show co-localization without proving direct binding. Each assay defines a different operational meaning of association.

### RNA-Binding Chromatin Regulators and Recruitment Models

Many chromatin regulators are RNA-binding proteins in the broad biochemical sense: they contain canonical RNA-binding domains, low-complexity regions, charged surfaces, zinc fingers, helicase domains, or intrinsically disordered regions that can contact RNA. Histone methyltransferases, demethylases, acetyltransferases, deacetylases, chromatin remodelers, Polycomb and Trithorax-associated proteins, mediator-associated factors, cohesin regulators, and nuclear matrix proteins have all been reported to interact with RNA in particular contexts. The interaction may be sequence-selective, structure-selective, length-dependent, charge-driven, or mediated by another protein.

Recruitment models usually fall into four categories. The guide model proposes that RNA contains information that helps a regulator find a genomic target. This information could be sequence complementarity to nascent RNA or DNA, folded RNA structure recognized by a protein, or association with a locus-specific transcription factor. The scaffold model proposes that an RNA organizes multiple factors, increasing the local concentration or stability of a regulatory complex. The tether model proposes that the act of transcription or a retention element keeps the RNA near a chromosomal region where it can influence nearby chromatin. The decoy or allosteric model proposes that RNA binding changes a regulator's availability or activity rather than guiding it to a target.

These models are not mutually exclusive. For example, a cis-acting lncRNA could be tethered near its transcription site, bind a histone-modifying complex through a repeated motif, and inhibit that complex at the same time. A promoter-associated RNA could recruit a protein in one system but act mainly as a marker of paused polymerase in another. The same chromatin regulator can also have different RNA-binding consequences depending on RNA concentration, salt conditions, post-translational modifications, accessory subunits, and chromatin template.

Evidence for recruitment needs to separate necessity from sufficiency. Necessity is tested by depleting the RNA or blocking its transcription and asking whether the chromatin regulator leaves the locus. Sufficiency is tested by artificially tethering the RNA, an RNA motif, or an RNA-binding protein to an ectopic site and asking whether the regulator is recruited. Stronger tests include rescue with mutant RNAs that preserve abundance but disrupt a binding motif, acute protein degradation to place RNA action upstream or downstream of the regulator, and measurement of chromatin state before secondary transcriptional effects dominate.

## 96.2. PRC2-RNA interactions, specificity debates, and regulatory consequences

PRC2 is a central case because it links RNA binding, histone modification, and gene repression. The core PRC2 complex contains EZH1 or EZH2 as the catalytic subunit, SUZ12, EED, and additional associated factors. Its best-known chromatin product is H3K27me3, a mark enriched at facultatively repressed developmental genes and Polycomb domains. PRC2 recruitment in mammals involves CpG-rich DNA, accessory proteins, existing H3K27me3 recognition through EED, transcriptional state, chromatin context, and local antagonism by active chromatin marks. RNA has been proposed as another layer in this targeting logic.

The early appeal of RNA-guided PRC2 recruitment came from lncRNA examples in which a specific RNA appeared to bind PRC2 and affect repression at defined loci. The guide interpretation was straightforward: the lncRNA recognizes a genomic region and brings PRC2 to deposit H3K27me3. Later biochemical and genomic work complicated this picture. PRC2 can bind many RNAs, including RNAs that are not obvious locus-specific guides. Binding can be influenced by RNA length, structure, G-rich sequences, repeats, and general electrostatic properties. In some assays, RNA binding inhibits PRC2 activity on chromatin templates, suggesting that RNA can restrain PRC2 rather than recruit it.

The specificity debate has three separable parts. First, biochemical specificity asks whether PRC2 distinguishes one RNA from many others under physiological conditions. Second, genomic specificity asks whether a particular RNA explains PRC2 localization at particular loci better than DNA sequence, CpG density, accessory proteins, transcriptional inactivity, or preexisting Polycomb chromatin. Third, functional specificity asks whether disrupting the RNA-PRC2 contact changes H3K27me3 and gene repression at the relevant targets without causing broad indirect effects. A convincing claim must address all three levels.

> **Box 96.1. A PRC2-RNA Claim Needs Three Kinds of Specificity**
>
> A recruitment claim must establish biochemical specificity of the interaction, genomic specificity of localization beyond CpG content and accessory proteins, and functional specificity linking the contact to PRC2 occupancy, H3K27me3, and repression. If one tier is missing, use the narrower claim supported by the evidence.

Consequences of PRC2-RNA binding can differ by context. RNA can help keep PRC2 away from active genes by occupying RNA-binding surfaces when transcription is high. RNA can stabilize a local ribonucleoprotein compartment that includes PRC2 but is not itself a precise address system. RNA can modulate catalytic activity, alter residence time, or affect competition between PRC2 and other chromatin proteins. In a subset of loci, RNA may contribute to local recruitment or spreading, especially when tethering keeps the RNA near a chromosomal region. The current field has moved away from a single universal model and toward locus-specific tests.

The local reference list for this chapter lacks a dedicated PRC2-RNA review or landmark primary-paper block. Final reference item: add verified PRC2-RNA sources covering XIST/Polycomb history, PRC2 promiscuous RNA binding, RNA-mediated inhibition or modulation of PRC2 activity, accessory-factor recruitment, and current consensus on Polycomb targeting. Until those references are curated, this subsection should be treated as expert synthesis rather than fully supported claim-level prose.

**Table 96.1. Mechanistic Models for RNA-Mediated Chromatin Regulation.** Chromatin-regulatory RNA models make distinct claims about recruitment, scaffolding, transcriptional interference, topology, and compartmentalization; discriminating evidence must separate each model from plausible DNA- or transcription-dependent alternatives.

| Model | Core claim | Discriminating evidence | Main alternative |
| --- | --- | --- | --- |
| **Guide** | RNA carries information that helps target a regulator | Motif-dependent occupancy and locus-specific rescue | DNA or protein targeting explains occupancy |
| **Scaffold** | RNA organizes multiple factors locally | Separable RNA domains support distinct contacts and output | Crosslinked neighborhood without functional assembly |
| **Tether** | Local production or retention raises effective RNA concentration | Cis dependence and local-tether rescue | RNA sequence is dispensable; transcription site is decisive |
| **Decoy or allosteric** | RNA changes regulator availability or activity | Activity changes without target-site recruitment | Apparent recruitment loss is catalytic modulation |
| **Transcription-coupled** | Polymerase passage or nascent processing changes chromatin | RNA depletion differs from transcriptional interference | RNA abundance is only a marker of enhancer activity |

## 96.3. Enhancer and promoter RNAs in chromatin-loop regulation

Enhancers are DNA elements that increase transcription from target promoters, often across large genomic distances. Active enhancers are characterized by transcription-factor occupancy, chromatin accessibility, H3K27ac, mediator and coactivator binding, and, in many cases, RNA polymerase II transcription. The resulting enhancer RNAs are usually short and unstable, but this generalization has important exceptions. Some enhancer-derived transcripts are longer, spliced, polyadenylated, or functionally closer to lncRNAs. Promoters also produce divergent, upstream, or promoter-proximal RNAs that can reflect paused polymerase, promoter architecture, or regulatory feedback.

An enhancer RNA can be a marker, a mediator, or both. As a marker, enhancer RNA indicates that a regulatory element is active enough to recruit polymerase and produce nascent transcript. This makes eRNA abundance useful for enhancer annotation, especially when combined with chromatin accessibility and histone acetylation. As a mediator, the RNA molecule or transcription process contributes to regulation. Proposed mechanisms include stabilizing mediator or cohesin at enhancer-promoter contacts, recruiting RNA-binding coactivators, facilitating local chromatin accessibility, promoting phase-separated transcriptional environments, or modulating histone modification enzymes.

Field and Adelman emphasized that enhancer function and enhancer transcription must be evaluated with experimental designs that distinguish DNA element activity, transcription factor binding, RNA polymerase II dynamics, and RNA products. Han and Li reviewed enhancer RNA biology as a field in which many transcripts are correlated with activation but only some have defined molecular functions. Recent work adds mechanistic detail. Barshad and colleagues linked RNA polymerase II dynamics to enhancer-promoter interactions, supporting the idea that transcription machinery behavior can shape three-dimensional communication. Li and colleagues reported that m6A on super-enhancer RNA promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Huang and colleagues described spatial control of m6A deposition on enhancer and promoter RNAs through co-acetylation of METTL3 and H3K27 on chromatin. These studies connect enhancer or promoter RNA metabolism to chromatin state, but they also show why enhancer RNA biology must be interpreted in the specific locus and cell context.

Enhancer-promoter looping is not simply a wire that RNA pulls into place. Contacts can be formed or stabilized by transcription factors, mediator, cohesin, CTCF, promoter architecture, compartmentalization, and polymerase-associated factors. RNA may influence these contacts by binding proteins that affect loop stability, by marking active regulatory hubs, by contributing to local condensate properties, or by maintaining an open chromatin environment. In some systems, enhancer transcription can precede or accompany looping; in others, preexisting contacts allow enhancer transcription and promoter activation. Time-resolved perturbation is needed to order these events.

> **Box 96.2. Separating Enhancer DNA, Enhancer Transcription, and Enhancer RNA**
>
> Contrast DNA deletion, transcriptional interference, RNA depletion, endogenous-locus rescue, ectopic expression, and artificial tethering. Each intervention changes different variables; the box asks which layer the experiment actually tested and which alternatives remain.

![Figure 96.2. Enhancer and Promoter RNA Mechanisms in Chromatin-Loop Regulation](../assets/figures/chapter1091_figure2.png)

**Figure 96.2. Enhancer and Promoter RNA Mechanisms in Chromatin-Loop Regulation.** Show enhancer transcription, promoter-proximal RNA, mediator or cohesin-associated contacts, RNA-binding coactivators, and distinct possible consequences for accessibility, H3K27ac, contact frequency, and target transcription. The visual must separate the RNA product from enhancer DNA and the act of transcription.

## 96.4. RNA tethering, chromatin remodeling, histone modification, and causal mechanisms

### RNA Tethering, Chromatin Remodeling, and Histone Modification Links

RNA tethering is a powerful concept because many chromatin-associated RNAs act near where they are made. A nascent RNA can remain close to chromatin through polymerase attachment, spliceosome or processing factors, RNA-binding proteins, R-loop formation, or association with nuclear scaffolds. Artificial tethering experiments use engineered RNA-binding systems to place an RNA or protein at a defined locus. If tethering an RNA motif recruits a chromatin regulator or changes a histone mark, the experiment supports sufficiency. If moving the RNA away from its locus abolishes function, the result supports a local-concentration model.

Tethering does not always mean the RNA sequence encodes a precise genomic address. A cis-acting RNA may work because its transcription site places it near susceptible chromatin. This distinction matters for therapeutic and engineering applications. If an RNA works through sequence-specific recognition, transferring it to another locus may redirect regulation. If it works through local tethering and chromatin context, the same RNA may fail elsewhere. Rescue experiments should therefore compare endogenous-locus expression, ectopic expression, artificial tethering, and mutant RNAs that preserve expression but disrupt candidate protein contacts.

Chromatin remodeling links RNA to nucleosome positioning and accessibility. Some RNA-binding remodelers or remodeling-associated factors may use RNA as a local signal of transcriptional activity. RNA can compete with nucleosomal DNA for basic protein surfaces, alter the residence time of remodeling complexes, or recruit proteins that change nucleosome occupancy. In enhancer-rich regions, nascent RNA and RNA-binding coactivators may help maintain accessible chromatin. In repressive regions, repeat-derived or lncRNA-associated ribonucleoprotein assemblies may help stabilize compact chromatin or recruit histone-modifying activities.

Histone modification links include H3K27me3 through PRC2, H3K27ac at active enhancers, methylation and acetylation states associated with promoter activity, and more specialized modifications that are still being evaluated. The relationship between RNA and histone marks can run in either direction. A histone modification can recruit machinery that promotes RNA production. An RNA can recruit or inhibit the enzyme that deposits a histone modification. A shared upstream factor can change both RNA and histone marks. For this reason, time-resolved and orthogonal perturbations are essential. Measuring RNA loss and histone-mark loss at the same endpoint is not enough to show that RNA controls the mark.

![Figure 96.3. RNA Tethering and Chromatin-Regulatory Outcomes](../assets/figures/chapter1091_figure3.png)

**Figure 96.3. RNA Tethering and Chromatin-Regulatory Outcomes.** Compare endogenous cis tethering, ectopic RNA expression, and engineered local tethering. Branches show recruitment, inhibition, altered regulator residence, remodeling, histone modification, or no effect when chromatin context is missing.

### Repeat-Derived RNAs and Chromatin Domains

Repeats are important because a large fraction of mammalian genomes is transcribed at some level and contains repetitive elements capable of producing RNA. Repeat-derived RNAs can provide many copies of related sequence motifs, bind abundant nuclear proteins, or contribute to domain organization. Alu elements are especially relevant in primates. Liang and colleagues reported that complementary Alu sequences can mediate enhancer-promoter selectivity, providing an example in which repeat-derived complementarity contributes to regulatory contact specificity. This does not mean every repeat-derived contact is functional, but it shows that repeated sequences can create a substrate for RNA- or RNA-like sequence-mediated chromatin communication.

Alpha-satellite RNAs and other pericentromeric repeat RNAs illustrate a different domain-level logic. They are associated with chromosome stability, centromeric or pericentromeric chromatin, and nuclear architecture in particular cell-cycle contexts. Ren and colleagues reported that chromatin-associated alpha-satellite RNA maintains chromosome stability by reestablishing SAF-A during the mitotic cell cycle. Such examples remind the reader that RNA-chromatin interaction is not restricted to gene promoters and enhancers. It also includes repetitive chromatin, chromosome segregation, nuclear scaffold contacts, and large-scale domain maintenance.

Repeat-rich RNAs are difficult to map because short reads and hybridization probes can cross-react with related sequences. Strong repeat-RNA studies therefore require careful probe design, multi-mapping-aware analysis, orthogonal validation, and perturbations that distinguish RNA function from the DNA repeat's own regulatory or structural role.

## Experimental Foundations and Evidence Bridges

Mapping establishes a candidate molecular neighborhood; imaging can establish single-cell heterogeneity and temporal proximity; chromatin profiling measures regulator occupancy, histone modification, accessibility, or chromosome contacts. None of these observations alone proves that an RNA molecule regulates chromatin. Named assays, probe design, normalization, ligation bias, optical resolution, and benchmarking belong to [Chapter 134](chapter1122.md).

Perturbation separates mechanism classes. Acute RNA depletion tests the RNA product, transcriptional interference tests production through the locus, minimal DNA edits test regulatory sequence, protein degradation places a chromatin factor upstream or downstream, and tethering tests whether local RNA is sufficient. Rescue must preserve the variable being tested: an ectopic RNA may not rescue a cis-tethered mechanism, whereas endogenous-locus or engineered-tether rescue can.

A causal chain should show that RNA or RNA-factor disruption precedes a change in regulator occupancy or activity, which precedes a chromatin-state change and then a transcriptional consequence. Multiple RNA reagents, separation-of-function mutants, early time points, and orthogonal evidence reduce indirect explanations. These are evidence roles rather than assay recipes.

![Figure 96.4. Causal Decision Tree for an RNA-Chromatin Mechanism](../assets/figures/chapter1091_figure4.png)

**Figure 96.4. Causal Decision Tree for an RNA-Chromatin Mechanism.** Begin with an RNA-locus or RNA-regulator association and ask whether acute RNA depletion, transcriptional interference, minimal DNA alteration, protein perturbation, time-resolved chromatin readouts, rescue, and tethering support an RNA-product mechanism, transcription mechanism, DNA-element mechanism, protein-mediated mechanism, or indirect consequence. Methods are evidence roles; implementation belongs to [Chapter 134](chapter1122.md).

![Figure 96.5. Competing Models for PRC2-RNA Interaction and Specificity](../assets/figures/chapter1091_figure5.png)

**Figure 96.5. Competing Models for PRC2-RNA Interaction and Specificity.** Draw scientific content from [Section 96.2](chapter1091.md), but place the ordered marker immediately after `[Chapter 96](chapter1091.md).fig.04` in the Experimental Foundations and Evidence Bridges section so the retired `.01` suffix remains unused and active figure IDs remain in reader order. Compare a selective-RNA model, a promiscuous nascent-RNA-sensor model, and a chromatin-first recruitment model. Separate sequence- or structure-biased binding, RNA-mediated local retention, catalytic inhibition, RNA release and chromatin engagement, and accessory-factor/CpG-driven recruitment. End with independent biochemical, genomic, and functional specificity tests rather than treating RNA binding alone as recruitment evidence.

## Biological Contexts

RNA-chromatin interactions are most interpretable when the biological context is explicit. Developmental gene clusters, imprinted loci, X-chromosome regulation, stimulus-responsive enhancers, cancer super-enhancers, repeat-rich heterochromatin, and viral or stress-induced nuclear states can all produce chromatin-associated RNAs. The same RNA class may behave differently across contexts. A lncRNA that is locally tethered in embryonic cells may be absent or diffuse in differentiated cells. An enhancer RNA that marks activation in one cell type may contribute to accessibility in another. PRC2-RNA binding can be influenced by transcriptional state and chromatin environment.

Cancer studies often focus on super-enhancers because these regions concentrate transcription factors, coactivators, chromatin accessibility, enhancer transcription, and oncogene regulation. The Li et al. study on super-enhancer RNA m6A in pancreatic ductal adenocarcinoma connects RNA modification, chromatin accessibility, and oncogene transcription. Such work is important because it moves beyond the idea that enhancer RNA is merely a transcript count and asks how RNA chemistry may affect chromatin regulatory output. The caveat is that cancer super-enhancers are highly context-specific and often embedded in altered signaling, copy-number changes, and transcription-factor networks.

Immune and stress responses provide another setting in which enhancer transcription, chromatin accessibility, and RNA-binding proteins change rapidly. Time is central in these systems. A stimulus may first activate transcription factors, then enhancer transcription, then enhancer-promoter contact changes, then mRNA output, and later chromatin memory or repression. Sampling only a late endpoint can invert cause and consequence. Acute time courses with nascent RNA, accessibility, chromatin contacts, histone marks, and RNA perturbation are therefore more informative than static comparisons.

## Technology, Computational, Clinical, and Engineering Links

Computational analysis of RNA-chromatin data must account for abundance, mappability, repetitiveness, genomic distance, compartment effects, and transcriptional activity. RNA-centric peaks should be compared with input, independent probe pools, RNA abundance, chromatin accessibility, and unrelated RNA controls. Global RNA-DNA contacts require normalization for both RNA abundance and DNA accessibility. Repetitive elements require special handling because reads may map to multiple loci or collapse distinct repeat copies into a consensus signal.

Engineering applications use RNA tethering to control chromatin state. Synthetic guide RNAs already recruit CRISPR-associated proteins to DNA, and catalytically inactive nucleases fused to chromatin modifiers can create local epigenome editing. RNA-based tethering expands this logic by placing RNA motifs or RNA-binding proteins near chromatin. The central design question is whether the RNA is meant to guide, scaffold, inhibit, or concentrate a regulator. Each design has different failure modes: off-target RNA binding, insufficient local concentration, inappropriate chromatin context, or broad sequestration of a chromatin regulator.

Clinical interpretation is still early. Some chromatin-associated RNAs and enhancer RNAs are disease biomarkers, and some may become therapeutic targets. However, biomarker correlation is much easier to establish than chromatin-regulatory mechanism. A disease-associated enhancer RNA may reflect oncogenic transcription rather than drive it. A lncRNA that binds a chromatin regulator in a pull-down may not be a safe or specific drug target. Therapeutic development requires evidence that perturbing the RNA changes disease-relevant chromatin or transcriptional programs with acceptable specificity.

## Recent Consensus

Recent consensus is that RNA is a normal component of nuclear chromatin regulation, but most RNA-chromatin associations need mechanism-specific validation. Chromatin-associated RNA can mark transcriptional state, help localize regulatory proteins, modulate enzyme activity, stabilize nuclear domains, or participate in enhancer-promoter communication. No single model explains all cases.

For PRC2, the consensus is cautious. PRC2-RNA binding is real and widespread, but broad RNA binding complicates claims that individual RNAs precisely guide PRC2. RNA can recruit, inhibit, modulate, or spatially constrain PRC2 depending on context. Claims about PRC2-RNA targeting should specify the locus, RNA, protein subunit, assay, and perturbation evidence.

For enhancer RNAs, the consensus is similarly conditional. Enhancer transcription is a useful marker of enhancer activity, and some enhancer RNAs have functional roles in chromatin accessibility, coactivator recruitment, RNA modification-linked regulation, or enhancer-promoter communication. Each case must separate RNA product function from transcription through enhancer DNA.

## Open Questions, Controversies, Deprecated Models, and Common Misconceptions

Open questions:

- How often chromatin-associated RNAs are causal regulators rather than consequences of active or repressed chromatin?
- What determines how RNA sequence, structure, modification, abundance, and transcription site combine to determine specificity? For many lncRNAs and enhancer RNAs, the field still lacks enough mutant-rescue evidence to map functional domains.

Controversies:

- The PRC2 controversy remains a useful warning. The deprecated oversimplification is that a lncRNA binds PRC2 and therefore guides PRC2 to target genes. The modern formulation asks whether the RNA-PRC2 contact is selective, whether it occurs at relevant concentrations, whether it changes PRC2 localization or activity, and whether perturbing the RNA changes H3K27me3 independently of transcriptional side effects.
- Methodological controversy centers on crosslinking and proximity. Formaldehyde can connect molecules that are nearby but not directly bound. Hybridization probes can recover repetitive or abundant RNAs nonspecifically. Ligation methods can favor accessible chromatin. Imaging can overcall proximity if nuclear geometry and random collision are not modeled. These problems are manageable when studies use orthogonal assays and explicit controls.

Common misconceptions:

- "Chromatin looping proves RNA function." A loop can be necessary for transcription, permissive for transcription, or a consequence of transcriptional activation.
- "Enhancer RNA detection proves the enhancer RNA molecule is functional." Detection proves transcription; function requires perturbation and rescue.